Key result
Aggressive treatment for statin-induced necrotizing autoimmune myopathy yields limited recovery amid therapeutic uncertainty.
Answers are grounded in this paper and cite their sources.
This case report highlights the therapeutic uncertainty and limited recovery associated with statin-induced necrotizing autoimmune myopathy despite aggressive treatment.
To present a case of Statin-induced necrotizing autoimmune myopathy (SINAM) in the absence of standardized guidelines.
No takes yet. Share an insight, caveat, or question.
Chacón et al. (2026) studied this question. Aggressive treatment for statin-induced necrotizing autoimmune myopathy yielded limited recovery, highlighting therapeutic uncertainty and a lack of standardized guidelines.
Synapse has enriched 10 related papers. Consider them for comparative context: